TSC1 and breast carcinoma: In this case of NF1‐associated breast cancer, mutations in the TP53, TSC1, and MAGI3 (PI3K/Akt/mTOR pathway) tumor suppressors are likely to cooperate with NF1 in carcinogenesis.